Topical pain management with the 5% lidocaine medicated plaster – a review
- 24 May 2012
- journal article
- research article
- Published by Taylor & Francis Ltd in Current Medical Research and Opinion
- Vol. 28 (6), 937-951
- https://doi.org/10.1185/03007995.2012.690339
Abstract
The topical 5% lidocaine medicated plaster is recommended as first-line treatment for localized peripheral neuropathic pain. In order to provide an overview of the efficacy and safety of the lidocaine plaster in the treatment of different neuropathic pain conditions, all efficacy and safety studies (randomized, controlled, or open-label with well described methodology), case reports, and pharmacological studies on the lidocaine plaster retrieved from a PubMed literature research (1960 – March 2012) plus additional references identified from retrieved articles were included. The lidocaine plaster is efficacious in the treatment of neuropathic pain symptoms associated with previous herpes zoster infection. Results from a large open-label controlled study suggest that the lidocaine plaster could be at least as effective as systemic pregabalin in the treatment of postherpetic neuralgia and painful diabetic polyneuropathy. Open-label studies indicate efficacy in the treatment of other localized neuropathic pain conditions, such as painful idiopathic sensory polyneuropathy, complex regional pain syndrome, carpal tunnel syndrome sequelae, postsurgical and posttraumatic pain. Quality of life markedly improved in a variety of neuropathic pain conditions and long-term treatment provided sustained relief in patients with neuropathic pain who are responsive to lidocaine plaster. The lidocaine plaster is usually well tolerated. The risk of systemic adverse events and pharmacokinetic interactions with concomitant medication is minimal owing to low systemic exposure. Treatment of several, primarily neuropathic and mixed-pain conditions with the 5% lidocaine medicated plaster was found efficacious and safe. Further controlled studies, in particular where only small open-label studies or case reports are available, should be considered.Keywords
This publication has 68 references indexed in Scilit:
- 5% Lidocaine Medicated Plaster in Elderly Patients with Postherpetic NeuralgiaDrugs & Aging, 2011
- Antihyperalgesic efficacy of 5% lidocaine medicated plaster in capsaicin and sunburn pain models – two randomized, double-blinded, placebo-controlled crossover trials in healthy volunteersExpert Opinion on Pharmacotherapy, 2011
- Use of Lidocaine Patch for Percutaneous Endoscopic Lumbar DiscectomyThe Korean Journal of Pain, 2011
- Sensitization in patients with painful knee osteoarthritisPain, 2010
- EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revisionEuropean Journal of Neurology, 2010
- Treatment Considerations for Elderly and Frail Patients With Neuropathic PainMayo Clinic Proceedings, 2010
- Recommendations for the Pharmacological Management of Neuropathic Pain: An Overview and Literature UpdateMayo Clinic Proceedings, 2010
- Prevalence and impact on quality of life of peripheral neuropathy with or without neuropathic pain in type 1 and type 2 diabetic patients attending hospital outpatients clinicsDiabetes & Metabolism, 2009
- A Preliminary fMRI Study of Analgesic Treatment in Chronic Back Pain and Knee OsteoarthritisMolecular Pain, 2008
- Herpes Zoster and Postherpetic NeuralgiaDrugs & Aging, 2008